Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

by | PRNewswire Asia

SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ — Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce a strategic research collaboration to develop next-generation...

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

by | PRNewswire Asia

HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ — Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a...

Driving the Global Food Revolution: Japan's Cutting-Edge Food Processing Technology Takes Center Stage

by | PRNewswire Asia

FOOMA JAPAN 2026 to Showcase Next-Generation Solutions Shaping the Future of Food Processing and Global Quality Standards TOKYO, April 30, 2026 /PRNewswire/ — The Japan Food Machinery Manufacturers’ Association (FOOMA) will host FOOMA JAPAN 2026, one...

Taimei Technology Debuts at BioKorea 2026, Showcasing AI-Powered Clinical Research Solutions

by | PRNewswire Asia

SEOUL, South Korea, April 30, 2026 /PRNewswire/ — Taimei Technology, a leading AI-driven drug clinical development platform, made its first public appearance in South Korea at BioKorea 2026, drawing significant attention with its advanced AI-powered clinical...

ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies

by | PRNewswire Asia

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ — ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in advanced...

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

by | PRNewswire Asia

HONG KONG, April 30, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the American Diabetes Association’s (ADA’s) 2026 Scientific Sessions, taking place...